Management of potential neurocysticercosis in patients with HIV infection

Sashank Prasad; Rob Roy MacGregor; Pablo Tebas; Lourdes B Rodriguez; Javier A Bustos; A Clinton White Jr

doi:10.1086/499359

Management of potential neurocysticercosis in patients with HIV infection

Clin Infect Dis. 2006 Feb 15;42(4):e30-4. doi: 10.1086/499359. Epub 2006 Jan 17.

Authors

Sashank Prasad¹, Rob Roy MacGregor, Pablo Tebas, Lourdes B Rodriguez, Javier A Bustos, A Clinton White Jr

Affiliation

¹ Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA. Sashank.prasad@uphs.upenn.edu

PMID: 16421784
DOI: 10.1086/499359

Abstract

In patients with human immunodeficiency virus, the diagnosis of neurocysticercosis can be complex, and the current diagnostic criteria may not apply. We report 3 cases and suggest including the CD4+ T lymphocyte count as an important factor in the proper diagnosis and treatment of patients with human immunodeficiency virus and potential neurocysticercosis.

Publication types

Case Reports

MeSH terms

Adult
Aged
Anthelmintics / therapeutic use
Anti-Retroviral Agents / adverse effects
Anti-Retroviral Agents / therapeutic use
CD4-Positive T-Lymphocytes / immunology
Female
Glucocorticoids / therapeutic use
HIV Infections / complications
HIV Infections / immunology*
Humans
Immunoassay
Immunocompromised Host*
Lymphocyte Count
Magnetic Resonance Imaging
Male
Middle Aged
Neurocysticercosis / blood
Neurocysticercosis / complications
Neurocysticercosis / diagnosis*
Neurocysticercosis / drug therapy*
Recurrence

Substances

Anthelmintics
Anti-Retroviral Agents
Glucocorticoids